Agenus Inc (NASDAQ: AGEN) kicked off on Tuesday, down -20.38% from the previous trading day, before settling in for the closing price of $3.90. Over the past 52 weeks, AGEN has traded in a range of $3.75-$19.69.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 98.93%. While this was happening, its average annual earnings per share was recorded 19.74%. With a float of $21.27 million, this company’s outstanding shares have now reached $21.57 million.
Let’s determine the extent of company efficiency that accounts for 389 employees. In terms of profitability, gross margin is 59.8%, operating margin of -71.27%, and the pretax margin is -144.94%.
Agenus Inc (AGEN) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Agenus Inc is 1.39%, while institutional ownership is 41.61%. The most recent insider transaction that took place on Feb 15 ’24, was worth 324,050. In this transaction an insider of this company bought 500,000 shares at a rate of $0.65, taking the stock ownership to the 625,969 shares. Before that another transaction happened on Nov 15 ’23, when Company’s Director bought 25,000 for $0.76, making the entire transaction worth $19,000. This insider now owns 124,063 shares in total.
Agenus Inc (AGEN) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 19.74% per share during the next fiscal year.
Agenus Inc (NASDAQ: AGEN) Trading Performance Indicators
Take a look at Agenus Inc’s (AGEN) current performance indicators. Last quarter, stock had a quick ratio of 0.37. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -11.21, a number that is poised to hit -2.24 in the next quarter and is forecasted to reach -9.67 in one year’s time.
Technical Analysis of Agenus Inc (AGEN)
Looking closely at Agenus Inc (NASDAQ: AGEN), its last 5-days average volume was 0.86 million, which is a jump from its year-to-date volume of 0.65 million. As of the previous 9 days, the stock’s Stochastic %D was 15.54%. Additionally, its Average True Range was 0.31.
During the past 100 days, Agenus Inc’s (AGEN) raw stochastic average was set at 0.79%, which indicates a significant decrease from 7.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 95.75% in the past 14 days, which was lower than the 167.87% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.82, while its 200-day Moving Average is $9.65. However, in the short run, Agenus Inc’s stock first resistance to watch stands at $3.56. Second resistance stands at $4.01. The third major resistance level sits at $4.30. If the price goes on to break the first support level at $2.82, it is likely to go to the next support level at $2.53. Should the price break the second support level, the third support level stands at $2.08.
Agenus Inc (NASDAQ: AGEN) Key Stats
The company with the Market Capitalisation of 66.98 million has total of 21,572K Shares Outstanding. Its annual sales at the moment are 156,310 K in contrast with the sum of -245,760 K annual income. Company’s last quarter sales were recorded 23,510 K and last quarter income was -53,080 K.
